What is the packaging size?

The product is packaged in 100mL bottles.

How should the product be stored?

Keep sealed in a cool, shady place and away from children.

Does the company offer OEM or ODM services?

Yes, the company offers both OEM and ODM services.

Calcium Gluconate Injection 25% for Livestocks and Poultry

Name: Calcium Gluconate Injection 25% for Livestocks and Poultry
Brand: Henan Muxiang Biological Co., Ltd.
SKU: 1989043525

Henan, ChinaHenan Muxiang Biological Co., Ltd.

US$1.21-1.58

1 Piece

Sample price:US$0.10/piece.Request sample

Product profile

Customization

Available

Varieties

General Disease Prevention Medicine

Component

Chemical Synthetic Drugs

Model NO.

Injection

Type

The First Class

Pharmacodynamic Influential Factors

Combined Medication

Storage Method

Light Proof

Veterinary Reg. No.

160220250

Transport Package

100ml/Bottle

Specification

100ml/bottle

Trademark

MOOSUN

Origin

Zhengzhou, Henan Province

HS Code

3004909099

Production Capacity

100000 Bottles/Month

Key features

Effective Calcium Treatment: Treats calcium deficiency, parturient paresis, rickets, and osteomalacia in livestock and poultry.

Broad Application Scope: Suitable for cattle, sheep, pigs, dogs, and poultry for various health conditions.

Hemostatic Function: Alleviates hemorrhagic diseases and central inhibition caused by magnesium ions.

Production Improvement: Improves milk and egg production while promoting growth and balancing body fluids.

Anaphylaxis Prevention: Prevents urticaria, serum sickness, and pulmonary edema caused by capillary permeability.

Stress Alleviation: Reduces stress from debeaking, vaccination, and climate changes in poultry.

OEM and ODM Services: Manufacturer offers both OEM and ODM customization services for veterinary products.

Established Manufacturer: Operating since 2004 with 360 employees and 20 R&D engineers.

Company profile

Henan Muxiang Biological Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-02-01 CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤10.68h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHenan Muxiang Biological Co., Ltd. is a China-based limited-company factory established in 2004, with 360 employees and operations in veterinary pharmaceuticals and animal-health products. The supplier reports seven pharmaceutical production lines, eight vaccine production lines, first-class production and inspection equipment, GMP management, ISO9001:2015 certification, and ISO/CNAS laboratory certification. Its R&D resources include more than 40 core personnel, over 30 of whom hold doctoral or master's degrees, while 21–30 quality-control staff are reported. The company exports to multiple global regions, has self-operated import and export rights, and states a one-month order-fulfillment period in both peak and off-peak seasons. Evidence supports capabilities in certification, innovation, production, and international operations. However, the provided information does not sufficiently establish after-sales service performance, financial credibility, customization execution, or specific customer cases.

Supplier typeThe supplier is identified as a limited company and a factory in the manufacturing industry, with its operating location in Henan, China. This indicates a direct manufacturing entity rather than only a trading or intermediary business.

CertificationsThe supplier reports a systematic GMP management system, ISO/CNAS laboratory international certification, and an ISO9001:2015 certificate. These stated certifications and quality systems provide explicit evidence of formal quality-management capability.

R&D capabilityThe supplier reports more than 40 core R&D personnel, including over 30 doctors or master's degree graduates, 20 years of preparation-technology experience among R&D engineers, and advanced R&D platforms such as a National Enterprise Technology Center, National Postdoctoral Research Station, and Academician Workstation. It also reports improving herbal active-ingredient extraction by more than 30% versus a traditional process, supporting a strong stated innovation profile.

Production capacityThe supplier reports seven pharmaceutical production lines and eight vaccine production lines, first-class production and inspection equipment, six production lines in a separate operational data field, and one-month order fulfillment in both peak and off-peak seasons. Although the line-count figures are not fully consistent across the slices, the evidence clearly supports substantial pharmaceutical and vaccine manufacturing capability.